Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cathepsins and elastases are distinct families of proteolytic enzymes that are often studied together due to their synergistic roles in tissue remodeling and inflammation. Cathepsins are primarily lysosomal proteases, categorized into cysteine (e.g., Cathepsin B, L, K), aspartic (e.g., Cathepsin D), and serine (e.g., Cathepsin G) proteases, involved in protein turnover and immune signaling (UniProt, 2023). Elastases, specifically neutrophil elastase (ELANE), are serine proteases secreted by activated neutrophils to degrade extracellular matrix proteins like elastin (PubMed, 2021). In diseases such as chronic obstructive pulmonary disease (COPD) and cystic fibrosis, an overabundance of these proteases leads to excessive lung tissue destruction and chronic inflammation (NIH, 2022). Additionally, Cathepsin L and elastase-like proteases are critical for the entry of certain viruses, including coronaviruses, by processing viral glycoproteins to facilitate membrane fusion (Nature, 2020). Therapeutic interventions include specific inhibitors like sivelestat for elastase or odanacatib for cathepsin K, though broad-spectrum protease inhibition remains a challenge due to potential off-target effects on normal physiological processes (PubChem, 2023).
Protease inhibition; competitive or non-competitive binding to the enzyme active site to prevent substrate cleavage.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cathepsin and elastase.